The group’s lobbying spending rose from $20 million in 2016 to $25.4 million in 2017 in response to increased public anger over high drug costs. The biggest jump came in the first quarter of 2017, when President Donald Trump accused pharmaceutical companies of “getting away with murder.”
PhRMA lobbying spending rose from $6 million in the first quarter of 2016 to $8 million in the first quarter of 2017. Much of their lobbying was focused on drug cost and policy issues.
“The other thing we have to do is create new bidding procedures for the drug industry, because they’re getting away with murder, pharma,” President Trump said in January 2016, according to The Hill. “Pharma has a lot of lobbies, a lot of lobbyists, a lot of power. And there’s very little bidding on drugs.”
More articles on leadership and management:
Community Hospital Corporation announces executive retirements
Workplace rudeness is on the rise, and it is on bosses to stop it: 3 things to know
CDC director misses 4th Congressional hearing due to conflict of interest
